Basilea Pharmaceutica AG (SWX:BSLN)

Basilea Pharmaceutica AG Income Statement

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	194.36	194.87	150.28	122.32	131.56
Other Revenue	38.03	13.68	7.36	25.45	16.56
Revenue	232.38	208.54	157.63	147.77	148.12
Revenue Growth (YoY)	11.43%	32.30%	6.68%	-0.24%	16.06%
Cost of Revenue	145.22	115.82	104.65	98.41	117.23
Gross Profit	87.16	92.72	52.99	49.36	30.89
Selling, General & Admin	34.91	31.02	31.08	28.55	27.89
Operating Expenses	34.91	31.02	31.08	28.55	27.89
Operating Income	52.25	61.7	21.91	20.81	3.01
Interest Expense	-3.36	-4.34	-11.2	-9.85	-8.15
Interest & Investment Income	1.27	1.42	1.69	0.33	0.07
Other Non Operating Income (Expenses)	-4.29	1.49	-1.94	0.81	-1.24
EBT Excluding Unusual Items	45.88	60.26	10.46	12.1	-6.31
Gain (Loss) on Sale of Assets	-	-	-	-	0.02
Other Unusual Items	-	-	-	-	-0.5
Pretax Income	45.88	60.26	10.46	12.1	-6.79
Income Tax Expense	5.64	-17.33	0.01	-0.05	0.04
Net Income	40.24	77.59	10.45	12.15	-6.83
Net Income to Common	40.24	77.59	10.45	12.15	-6.83
Net Income Growth	-48.14%	642.45%	-13.96%	-	-
Shares Outstanding (Basic)	12	12	12	12	12
Shares Outstanding (Diluted)	14	14	12	12	12
Shares Change (YoY)	-1.23%	14.10%	1.67%	2.24%	13.62%
EPS (Basic)	3.29	6.42	0.87	1.02	-0.58
EPS (Diluted)	3.14	5.82	0.86	1.02	-0.58
EPS Growth	-46.05%	577.28%	-15.69%	-	-
Free Cash Flow	59.47	72.65	13.43	3.92	-32.6
Free Cash Flow Per Share	4.35	5.24	1.11	0.33	-2.79
Gross Margin	37.51%	44.46%	33.62%	33.40%	20.86%
Operating Margin	22.48%	29.59%	13.90%	14.09%	2.03%
Profit Margin	17.32%	37.21%	6.63%	8.22%	-4.61%
Free Cash Flow Margin	25.59%	34.84%	8.52%	2.65%	-22.01%
EBITDA	54.06	63.43	23.19	21.71	3.56
EBITDA Margin	23.27%	30.42%	14.71%	14.69%	2.40%
D&A For EBITDA	1.81	1.73	1.28	0.9	0.55
EBIT	52.25	61.7	21.91	20.81	3.01
EBIT Margin	22.48%	29.59%	13.90%	14.09%	2.03%
Effective Tax Rate	12.28%	-	0.10%	-	-
Revenue as Reported	232.38	208.54	157.63	147.77	148.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.